Elizabeth has been involved in clinical trials and drug development for over 27 years. Elizabeth has worked on all sides of the clinical trial portfolio – hospital (site) as clinical trials and therapeutic pharmacist for haematology/oncology/palliative care units; Project manager for Australian ASX listed biotech company Phase I First in Human to Phase II; Director of Clinical Operations for another Australian biotech company (sponsor) Phase I to Phase III and now IQVIA (CRO) as Director of Strategic Site Relationships. Current role for over 15 years working within the global CRO and being the single contact point for the ANZ clinical trial sites. Elizabeth is there to advocate for sites and support sites conducting clinical trials. Elizabeth’s passion is working with sites and sponsors to increase the speed and efficiency of patient recruitment and clinical research within ANZ to bring new medicines to patients faster.